Timothe Luwawu-Cabarrot diagnosed with knee tendonitis

By Sean Kennedy (@PhillyFastBreak)

Embed from Getty Images

In a rare turn of events, the likes of which we’ve never seen before, a Sixers player is dealing with knee-related problems. The latest news involves Timothe Luwawu-Cabarrot, with Sportando reporting that the 22-year-old has patellar tendinopathy and will miss the Eurobasket tournament with the French national team.

Tendinopathy is another word for tendonitis; this condition is commonly referred to as jumper’s knee. Rest and stretching/range-of-motion exercises are the best treatments for the condition. We have no idea of the level of seriousness for Luwawu-Cabarrot; there’s no reason to think he shouldn’t be ready for training camp in the fall.

If TLC was experiencing any discomfort, it may explain his poor showing in summer league play. The rising NBA sophomore was expected to take on more of a leadership role in Salt Lake City and Vegas, but struggled on the court, averaging just 8.88 points on 36.9% shooting across 8 games. Maybe the knee has just started to bother him, or he may not have mentioned anything until now, but it wouldn’t be shocking if the crack Sixers training staff missed yet another diagnosis.

While there’s every possibility this is just a short term issue, this summer seems like a waste of developmental opportunity for Luwawu-Cabarrot, especially after he finished the regular season of his rookie year so well. In 6 April games with the Sixers, Luwawu-Cabarrot averaged 18.3 points on 44.9% shooting and 1.8 steals. Now, he’s had a subpar summer league, needing to get stitches in his lip along the way, and will miss going up against strong competition in EuroBasket.

With J.J. Redick and Furkan Korkmaz arriving, and Jerryd Bayless back healthy, minutes will be much more crowded on the wings this upcoming season. However minor, this knee tendonitis is not a good harbinger for TLC makes the leap and carving out a significant role for himself going forward.


Add Comment Register



Leave a Reply

Your email address will not be published. Required fields are marked *